2026-10-25
Does not pass
QTREX Quantum does not pass the ethical screen. The binding factor is interest/revenue 22.1%.
NAS100 29,709 +0.19%
S&P 7,737 +0.19%
GOLD $4,053 −0.54%
BTC $80,942 +0.17%
VIX 17.29 −1.31%
latest tape · as of 18:04 UTC
The Screen · Technology
QTREX Quantum Ltd.
QTEX · Nasdaq · USD · Market cap $81M
FAIL · Does not pass the screen1.39 USD
Price as of 23 Oct 2026Daily close, not a live quoteLast reviewed 5 days ago
Screened 2026-10-23 · the tape above runs as of 18:04 UTC · two dates, stated on purpose · verdict and workings shown in full · never trimmed
Key facts today
- Price1.39 USD at the 23 Oct 2026 close
- Ethical screenDoes not pass
- Last reviewed23 Oct 2026 (5 days ago)
A summary of the dated readings below, not a live quote and not advice.
PRICE · FAIR-VALUE RANGE1M3M6MYTD1Y3Y5Y
What this means: price 1.39 against the desk's fair-value range, over the last year.
- Trend Markup
- Insiders insiders bought, latest filing 2026-10-13
- Positioning no disclosures inside 60 days, left as found
- Options no verdict drawn today, left as found
- Ethical does not pass the values gate
Price1.39 USD
Our investment reviews on this name
2026-10-11Read Markup0.76+82.8% to today ✓Distribution gives way to Markup after a 9% slide in 4 weeks
2026-09-10Read Distribution0.83+66.8% to today Markup gives way to Distribution after a 41% slide in 10 weeks
2026-07-02Read Markup1.42-2.1% to today First review on file: Markup
Our analytic regime reads on this name, dated and marked against the screened price. Small sample per name, and separate from the daily-framework accuracy on the Track Record page.
The full research record, in depth, below
This name holds its markup label.
QTREX Quantum Ltd. holds its Markup at $1.39. Consolidating, no directional conviction, held for 14 days.
| Phase | Markup |
| Quantitative state | Consolidating, no directional conviction, held for 14 days |
| Price at the screen | $1.39 |
| Valuation | N/A trailing · N/A forward price to earnings |
| Values screen | FAIL |
| Beta | 4.24 |
Five Screens, Shown in Full
Does not pass. Interest/revenue 22.1%
| Test | Figure | Limit | What it means | Status |
|---|---|---|---|---|
| Business activity | Permissible | Core business clean | Its core business isn't built on prohibited lines: no gambling, alcohol, tobacco, weapons, or interest-based lending. | Pass |
| Debt load | 1.52% | Below 33% | Interest-bearing debt is just 1.5% of its assets, well under the one-third ceiling: it does not run on borrowed money. | Pass |
| Interest-bearing cash | 9.97% | Below 33% | Cash held in interest-bearing accounts and securities is 10.0% of assets, under the one-third limit. | Pass |
| Receivables | 0.00% | Below 49% | Money owed to the company is 0.0% of assets, under the 49% limit. | Pass |
| Revenue purity | 22.15% | Below 5% | 22.1% of revenue comes from non-compliant sources, over the 5% line. | Fail |
Five checks adapted from AAOIFI screening standards: business activity plus four balance-sheet ratios. All five must pass for ethical clearance. Every figure is arithmetic on public accounts, not judgement.
The Ethical ReadWhy It Falls Short, in Plain English
QTREX Quantum does not pass the ethical screen. The binding factor is interest/revenue 22.1%.
Read as at 2026-10-27. It updates when the underlying figures move, and past reads are kept below.
2026-09-24
Clears
QTREX Quantum clears all five screens. Its business is in a permissible area, its debt is near-nil, and almost none of its income is interest, so it passes.
Earlier reads, kept as written. The ethical profile is tracked over time, not overwritten.
Follow this verdict
Get an email when QTEX's ethical verdict changes
Today QTEX does not pass the screen. If new figures move it to a pass, we send you one short email with the before and after. Verdicts change rarely, so you may not hear from us for a long time.
Free, no account needed. Every email has a link to stop.
The Fair Value Range
Reading the gap · Our more conservative model reads it as fully-to-richly valued here, while the Street is more bullish: a quality-at-a-fair-price name rather than a deep-value one.
Price History & ProjectionsWhere it has been, where the models see it going. History from market close data; projection points are our fair-value estimates and third-party analyst targets, dated to the 2026-10-23 screen.
Fair value and rating are our own model estimates; the Street's range reflects third-party analyst estimates. Analysis, not advice.
The Business, in Plain Words| EPS, trailing | -0.35 |
| Revenue growth | +437.7%growing very fast |
| Profit margin | 0.0%currently unprofitable |
| Return on equity | -219.3%not currently earning a positive return on equity |
| FCF yield | -6.83% |
| Debt to equity | 0.26minimal debt: a conservative balance sheet |
| Current ratio | 2.00healthy short-term liquidity |
| Beta | 4.24much more volatile than the market |
| Short interest, float | 0.05% |
| 52-week range | 0.28 - 3.85 |
| Market cap | $81M |
The risks · The things to watch: it's a small-cap, so the share price can swing harder than the market; it already moves more than the market on an average day.
Plain-English interpretation of our own screen data. Analysis, not advice.
Where & How to TradeQTEX trades on Nasdaq. As a listed security it is accessible through almost any international broker offering its home market. New to this, or investing from abroad? Our guide to accessing global markets covers brokers, currencies and the practical steps.
Every Entry, As Written
2026-10-26
Markup $1.58
+107.8% Entry 8
The analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved up 107.8% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B. Technically it is holding around 45% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 104%. Our forward projection puts the odds of a 10% gain over the next month near 31%. The street (1 analysts) rates it none, with a mean price target of $5. Insiders have been net buyers over the past quarter.
2026-10-11
Markup · changed $0.76
+0.0% Entry 7
The framework has shifted from distribution to markup since the last review. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it A. Technically it is sitting below its long-term trend line with momentum reading overbought. Over the past year the shares are up 104%. Our forward projection puts the odds of a 10% gain over the next month near 31%. The street (1 analysts) rates it none, with a mean price target of $5. Insiders have been net buyers over the past quarter.
2026-10-02
Distribution $0.76
-8.8% Entry 6
Our analysis reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 8.8% since our last review. Ethical screening: PASS with ethical screening pending. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it A. Technically it is sitting below its long-term trend line with momentum reading overbought. Over the past year the shares are up 104%. Our forward projection puts the odds of a 10% gain over the next month near 31%. The street (1 analysts) rates it none, with a mean price target of $5. Insiders have been net buyers over the past quarter.
2026-09-10
Distribution · changed $0.83
-22.8% Entry 5
The framework has shifted from markup to distribution since the last review. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 22.8% since our last review. Ethical screening: PASS with ethical screening pending. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it A. Technically it is sitting below its long-term trend line with momentum reading overbought. Over the past year the shares are up 104%. Our forward projection puts the odds of a 10% gain over the next month near 31%. The street (1 analysts) rates it none, with a mean price target of $5.
2026-08-09
Markup $1.08
-23.9% Entry 4
Our analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 23.9% since our last review. Ethical screening: PASS with ethical screening pending. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it A. Technically it is sitting below its long-term trend line with momentum reading overbought. Over the past year the shares are up 104%. Our forward projection puts the odds of a 10% gain over the next month near 31%. The street (1 analysts) rates it none, with a mean price target of $5.
2026-07-18
Markup $1.42
+0.0% Entry 3
Our analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: PASS with ethical screening pending. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it A. Technically it is sitting below its long-term trend line with momentum reading overbought. Over the past year the shares are up 104%. Our forward projection puts the odds of a 10% gain over the next month near 31%. The street (1 analysts) rates it none, with a mean price target of $5.
2026-07-03
Markup $1.42
+0.0% Entry 2
Our analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: PASS with ethical screening pending. The risk-adjusted return profile shows modest positive risk-adjusted returns.
2026-07-02
Markup $1.42
Entry 1
Our analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Ethical screening: PASS with ethical screening pending. The risk-adjusted return profile shows modest positive risk-adjusted returns.
Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.
- QTREX Announces Receipt of Nasdaq Notification Regarding Minimum Bid Price Requirement Yahoo Finance · 19d ago
- BC-Most Active Stocks Yahoo Finance · 23d ago
- QTREX Interconnect Independently Tested at 20 mK by a Leading Quantum Computing Company; Over 100 dB Channel Isolation, 60 dB Beyond the Market Leader Yahoo Finance · 27d ago
- QTREX Quantum Reports First Half 2026 Financial Results Yahoo Finance · 24 Sep 2026
- One of Israel’s 3 Largest Defense Companies Begins Immediate Deployment of QTREX Quantum’s AME Technology Yahoo Finance · 2 Sep 2026
Headlines from third-party outlets, linked for reference: not our reporting, not advice.
CSAICloudastructure Inc.
CSPICSP Inc
ODYSOdysight.ai Inc
AEYEAudioEye Inc
WATTEnergous Corp
ZEPPZepp Health Corp ADR
Screened names in the same industry · explore each on its own page.
| Date | Insider | Title | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-10-13 | Ben-Noon Dagi Shahar | CEO | P - Purchase | 14,093 | $20,999 |
| 2026-10-09 | Ben-Noon Dagi Shahar | CEO | P - Purchase | 18,181 | $30,362 |
| 2026-09-28 | Ben-Noon Dagi Shahar | CEO | P - Purchase | 168,894 | $119,543 |
Public filings, recorded as found. The full tape lives at Insider Intelligence.
| Period | Price then | Price return | Divs per share | $1,000 became | Total return |
|---|---|---|---|---|---|
| 1 month | $0.41 | +251.4% | · | $3,514 | +251.4% |
| 2 months | $0.43 | +236.5% | · | $3,365 | +236.5% |
| 3 months | $0.56 | +153.6% | · | $2,536 | +153.6% |
| 6 months | $1.13 | +26.6% | · | $1,266 | +26.6% |
| 1 year | $0.70 | +103.7% | · | $2,037 | +103.7% |
| 2 years | $2.02 | -29.2% | · | $708 | -29.2% |
| 3 years | $1.44 | -0.7% | · | $993 | -0.7% |
Historical returns from market close data. Past performance does not guarantee future results.
This entry now belongs to the ledger. Whatever QTEX does next, these words stay.
Membership
Thirteen thousand names carry this page. One desk keeps them honest.
Membership opens the full screen archive, the composites built from it, and the daily coverage that prices what the screen approves.
Join the deskScreening is research, not a fatwa and not financial advice. Figures are drawn from public accounts at the screen date shown. Always manage your risk.